Herbas VPB

Print
EN | LT
LT - COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY
EN - COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/00
A61K 38/20
A61K 39/395
A61K 45/06
A61P 35/00
European patent
(11) Number of the document 2766035
(13) Kind of document T
(96) European patent application number 12780684.2
Date of filing the European patent application 2012-10-10
(97) Date of publication of the European application 2014-08-20
(45) Date of publication and mention of the grant of the patent 2018-03-28
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2012/070088
Date 2012-10-10
PCT application publication
(87) Number WO 2013/053775
Date 2013-04-18
Priority applications
(30) Number Date Country code
11184644 2011-10-11 EP
11188625 2011-11-10 EP
12185108 2012-09-19 EP
Inventors
(72)
BECHER, Burkhard., CH
VOM BERG, Johannes., CH
Grantee
(73) Universität Zürich Prorektorat MNW, Rämistrasse 71, 8006 Zürich, CH
Title
(54) COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY
  COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY
Last update date 2021-04-30